EpiEndo gets regulatory approval for first patient study of first non-antibiotic macrolide
EpiEndo Pharmaceuticals, a clinical-stage biopharma company developing therapeutics for chronic inflammatory diseases, has received regulatory…
November 14, 2022 - 3 minutes